Symbols

ACHV

Achieve Life·NASDAQ

--(--)

Signals Analysis

Bullish signal 2

Bearish signal 0

EPS Beats Expectation

RSI Oversold

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About ACHV

Achieve Life Sciences, Inc.

A late-stage clinical pharmaceutical company that develops and commercializes cytisinicline for smoking cessaton and nicotine addiction

Industry

Pharmaceutical

Established Date

Listing Date

10/12/1995

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.achievelifesciences.com

Security Type

Common stock

Office address

1040 West Georgia Street, Suite 1030, Vancouver, B.C. V6E 4H1

Business

Introduction

Achieve Life Sciences, Inc., was incorporated in California in October 1991 and subsequently reorganized as a Delaware corporation in March 1995. The company is a late-stage clinical specialty pharmaceutical company with the sole mission of responding to the global nicotine dependence epidemic by developing and commercializing cytisinicline.

Company Financials

EPS

ACHV has released its 2025 Q4 earnings. EPS was reported at -0.28, versus the expected -0.27, missing expectations. The chart below visualizes how ACHV has performed over recent quarters, highlighting trends in earnings surprises.